REGULATION OF P53 PROTEIN EXPRESSION IN HUMAN BREAST-CANCER CELL-LINES

被引:0
|
作者
VOJTESEK, B
LANE, DP
机构
[1] UNIV DUNDEE, CANC RES CAMPAIGN LABS, DUNDEE DD1 4HN, SCOTLAND
[2] MASARYK INST ONCOL, CS-65653 BRNO, CZECHOSLOVAKIA
关键词
P53; BREAST CANCER; EXPRESSION;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mutation of the p53 gene is a common occurrence in human breast cancers but is by no means universal. However, even in tumours where the gene is not mutated altered levels of p53 protein are often detected. This is also observed in cell lines derived from human breast cancers. By transfecting such cell lines containing either wild type or mutant p53 genes with a temperature-sensitive mutant mouse p53 gene we have established that the cellular environment plays a critical role in the regulation of p53 protein expression. The results suggest that tumours that aberrantly express wild-type p53 may have lost the normal growth regulatory response to the protein and thus be functionally similar to those expressing the mutant protein.
引用
下载
收藏
页码:607 / 612
页数:6
相关论文
共 50 条
  • [41] EXPRESSION OF P53 IN HUMAN LEUKEMIC-CELL LINES
    KRAISS, S
    ESPIG, R
    VETTER, U
    HARTMANN, W
    MONTENARH, M
    LEUKEMIA RESEARCH, 1990, 14 (11-12) : 1041 - 1051
  • [42] COMBINED EFFECTS OF LONIDAMINE AND TAMOXIFEN IN HUMAN BREAST-CANCER CELL-LINES
    GORNATI, D
    ZAFFARONI, N
    ORLANDI, L
    DIFRONZO, G
    SILVESTRINI, R
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 6 (05) : 993 - 996
  • [43] MECHANISMS OF RESISTANCE TO ANSAMYCIN ANTIBIOTICS IN HUMAN BREAST-CANCER CELL-LINES
    BENCHEKROUN, MN
    SCHNEIDER, E
    SAFA, AR
    TOWNSEND, AJ
    SINHA, BK
    MOLECULAR PHARMACOLOGY, 1994, 46 (04) : 677 - 684
  • [44] MUTANT P53 PROTEIN ASSOCIATED WITH CHEMOSENSITIVITY IN BREAST-CANCER SPECIMENS
    KOECHLI, OR
    SCHAER, GN
    SEIFERT, B
    HORNUNG, R
    HALLER, U
    EPPENBERGER, U
    MUELLER, H
    LANCET, 1994, 344 (8937): : 1647 - 1648
  • [45] OVEREXPRESSION OF P53 AND PROGNOSIS IN BREAST-CANCER
    FRIEDRICHS, K
    GLUBA, S
    EIDTMANN, H
    JONAT, W
    CANCER, 1993, 72 (12) : 3641 - 3647
  • [46] P53 ALTERATIONS IN HUMAN SQUAMOUS-CELL CARCINOMAS AND CARCINOMA CELL-LINES
    CAAMANO, J
    ZHANG, SY
    ROSVOLD, EA
    BAUER, B
    KLEINSZANTO, AJP
    AMERICAN JOURNAL OF PATHOLOGY, 1993, 142 (04): : 1131 - 1139
  • [47] DATABASE OF P53 GENE SOMATIC MUTATIONS IN HUMAN TUMORS AND CELL-LINES
    HOLLSTEIN, M
    RICE, K
    GREENBLATT, MS
    SOUSSI, T
    FUCHS, R
    SORLIE, T
    HOVIG, E
    SMITHSORENSEN, B
    MONTESANO, R
    HARRIS, CC
    NUCLEIC ACIDS RESEARCH, 1994, 22 (17) : 3551 - 3555
  • [48] P53 AND KIRSTEN-RAS MUTATIONS IN HUMAN MESOTHELIOMA CELL-LINES
    METCALF, RA
    WELSH, JA
    BENNETT, WP
    SEDDON, MB
    LEHMAN, TA
    PELIN, K
    LINNAINMAA, K
    TAMMILEHTO, L
    MATTSON, K
    GERWIN, BI
    HARRIS, CC
    CANCER RESEARCH, 1992, 52 (09) : 2610 - 2615
  • [49] P53 EXPRESSION IN HUMAN BREAST-CANCER RELATED TO SURVIVAL AND PROGNOSTIC FACTORS - AN IMMUNOHISTOCHEMICAL STUDY
    OSTROWSKI, JL
    SAWAN, A
    HENRY, L
    WRIGHT, C
    HENRY, JA
    HENNESSY, C
    LENNARD, TJW
    ANGUS, B
    HORNE, CHW
    JOURNAL OF PATHOLOGY, 1991, 164 (01): : 75 - 81
  • [50] PROGNOSTIC VALUE OF P53 PROTEIN EXPRESSION IN BREAST CANCER
    Ben Slama, S.
    Bacha, D.
    Ben Amor, A.
    Halouani, A.
    Lahmar, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A33 - A33